Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Allina/Abbott Northwestern reports on 340B savings, community investments and neighborhood programs
Summary
Allina Health representatives presented the annual 340B drug-pricing program update and the Abbott Northwestern memorandum of understanding with the city, detailing charity care, early childhood vision screening, a community solar project, workforce-diversity efforts and an impact-investment commitment.
Representatives from Allina Health and Abbott Northwestern presented the committee on April 9 about the 340B drug-pricing program, the hospital’s memorandum of understanding with the City of Minneapolis, and community investments supported by program savings.
Why it matters: 340B is a federal drug-pricing program administered by the Health Resources and Services Administration (HRSA) that allows qualifying hospitals to purchase outpatient drugs at discounted rates; hospitals often use those savings to fund charity care, reduced-cost services and community programs. The committee received an annual report required by the hospital’s MOU with the city.
Tony Collins Kwong, director of system pharmacy strategic sourcing…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
